Filing Details
- Accession Number:
- 0001140361-14-017343
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-04-23 17:04:47
- Reporting Period:
- 2014-04-21
- Filing Date:
- 2014-04-23
- Accepted Time:
- 2014-04-23 17:04:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1037760 | Cepheid | CPHD | Laboratory Analytical Instruments (3826) | 770441625 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1189846 | L John Bishop | C/O Cepheid 904 Caribbean Drive Sunnyvale CA 94089 | Chairman Of The Board And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-04-22 | 42,349 | $11.94 | 82,199 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-04-22 | 42,349 | $46.11 | 39,850 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Acquisiton | 2014-04-21 | 19,500 | $0.00 | 19,500 | $0.00 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Acquisiton | 2014-04-21 | 176,250 | $0.00 | 176,250 | $45.84 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-04-22 | 42,349 | $0.00 | 42,349 | $11.94 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 19,500 | No | 4 | A | Direct | ||
| 176,250 | 2021-04-21 | No | 4 | A | Direct | |
| 107,651 | 2014-04-25 | No | 4 | M | Direct |
Footnotes
- Includes a total of 674 shares acquired under the Issuer's Employee Stock Purchase Plan on January 31, 2011, July 29, 2011 and January 31, 2012. As the result of an administrative error, such previous ESPP purchases were not reported on prior Forms 4 filed by the Reporting Person.
- Represents the aggregate of sales effected on the same day at different prices.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $46.00 to $46.18 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- 25% of the RSUs vest on the one-year anniversary of the grant date, then 6.25% of the RSUs vest each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting.
- 25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.083% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
- The stock option grant is 100% vested and immediately exercisable.
Billionaire Hedge Funds
